1 / 11

Monitoring and Evaluation in the Transition

Monitoring and Evaluation in the Transition. Toyin Jolayemi – APIN Ltd Seema Meloni - Harvard. Background. Harvard supporting sites since 2004 Since 2008, APIN has been funded by CDC Nigeria to transition sites from Harvard. Service Delivery.

ray
Télécharger la présentation

Monitoring and Evaluation in the Transition

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Monitoring and Evaluation in the Transition Toyin Jolayemi – APIN Ltd Seema Meloni - Harvard

  2. Background • Harvard supporting sites since 2004 • Since 2008, APIN has been funded by CDC Nigeria to transition sites from Harvard

  3. Service Delivery • Based on National Guidelines and Harvard/APIN protocols

  4. Overall Enrollment

  5. QA/QI (1): Continuity of Care

  6. QA/QI (2): OIs including TB

  7. QA/QI (3): Patient Monitoring

  8. Cohort Analysis

  9. Clinical Outcomes

  10. Transition of QA Efforts Site • Site QA committee in place including focal person and data staff • QA framework/plans in place • QA activities ongoing • Sites starting to run data for QI • Training on QA/QI framework and processes APIN Central • Central QA committee in place • QA indicators harmonised with GON • QA/QI toolkit in place • Training on QA/QI framework and processes • Mentoring of Sites Technical Assistance from Harvard • QA /QI SOP and QUiC tool developed; • Analysis for QI • Support training and provide TA on QA/QI

  11. Summary • Development of tools to monitor the impact of transition on clinical outcomes is critical. • Methods of analysis and ultimate significance require empirical approach. • Increased communication with transitioned site personnel and patients will inform the process.

More Related